Streetbeat News

Earnings

SLNG

Stabilis Solutions (NASDAQ:SLNG) reported Q2 losses of $(0.12) per share, unchanged from the same period last year. Sales for the quarter were $12.91 million, a decrease of 49.94% from $25.78 million YoY.

Portfolio Pulse from saritha@benzinga.com

August 09, 2023 | 9:22 pm

UHAL

U-Haul Holding has reported its Q1 earnings per share (EPS) at $1.27.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 9:21 pm

RADI

Radius Global Infrastructure (NASDAQ:RADI) reported Q2 losses of $(0.43) per share, missing the analyst consensus estimate of $(0.31) by 38.71%. The company also reported quarterly sales of $42.48 million, missing the estimate of $42.95 million by 1.11%. This represents a 115% increase in losses and a 30.42% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 9:20 pm

AMSC

American Superconductor (NASDAQ:AMSC) reported Q1 adjusted EPS of $(0.08), beating the estimate of $(0.16) by 50%. The company also reported quarterly sales of $30.25M, surpassing the estimate of $27.75M by 9.02%. This represents a 68% increase in EPS and a 33.40% increase in sales compared to the same period last year.

Portfolio Pulse from sunil@benzinga.com

August 09, 2023 | 9:20 pm

OR

Osisko Gold Royalties (NYSE:OR) reported Q2 earnings of $0.13 per share, beating the analyst consensus estimate of $0.11 by 21.82 percent. This represents a 770 percent increase over losses of $(0.02) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 9:18 pm

CGC

Canopy Growth reported Q1 sales of $109.00 million, beating the analyst consensus estimate of $67.98 million by 60.34 percent. This represents a 26.32 percent increase over sales of $86.29 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 9:18 pm

RPTX

Repare Therapeutics reported Q2 earnings per share of $(0.28), beating the analyst consensus estimate of $(0.78) by 64.1%. The company also reported quarterly sales of $30.25 million, surpassing the analyst consensus estimate of $7.68 million by 293.87%. This represents a significant increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 9:18 pm

CYCC

Cyclacel Pharmaceuticals reported Q2 losses of $(0.44) per share, beating the analyst consensus estimate of $(0.50) by 12 percent. This is a 4.35 percent increase over losses from the same period last year. The company reported $373.00 thousand in sales this quarter.

Portfolio Pulse from sunil@benzinga.com

August 09, 2023 | 9:18 pm

ERF

Enerplus reported Q2 earnings of $0.39 per share, missing the analyst consensus estimate of $0.63 by 38.1%. This is a 44.29% decrease from the same period last year. The company's sales this quarter were $357.90 million, a 38.34% decrease from the same period last year.

Portfolio Pulse from totan@benzinga.com

August 09, 2023 | 9:18 pm

DIS

Disney CEO, Iger, expressed optimism about improving margins in the streaming business over the next few years during a conference call.

Portfolio Pulse from Charles Gross

August 09, 2023 | 9:18 pm